Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant718 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05901779 | Effect of Probiotic Supplements on Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy | unknown | N/A | 318 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Jun 13, 2023 | clinicaltrials |
| NCT05699278 | Investigating the Experiences of Individuals With Gastric Cancer Participating in Clinical Trials | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 0 | Jun 12, 2023 | clinicaltrials |
| NCT05886075 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors | unknown | Early Phase 1 | 24 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Jun 2, 2023 | clinicaltrials |
| NCT04631731 | Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity(ICEMELT) | unknown | Phase 1 / Phase 2 | 200 | Western Sydney Local Health DistrictOTHER | 1 | Jun 1, 2023 | clinicaltrials |
| NCT05393986 | Claudin18.2-redirected Chimeric Antigen Receptor T Cells With Co-expression of Cytokines in Solid Tumors | unknown | Phase 1 | 63 | Peking UniversityOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05596188 | Anxiety Before Non-cardiac Surgery in Adults | unknown | — | 424 | RenJi HospitalOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05856500 | A Study of Creatine Combined With Curcumin in the Intervention of Early Cachexia in Upper Gastrointestinal Tumors | unknown | N/A | 152 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 0 | May 18, 2023 | clinicaltrials |
| NCT05860374 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors | unknown | Early Phase 1 | 20 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | May 16, 2023 | clinicaltrials |
| NCT05853172 | Surgical Conversion of Candonilimab (AK104) Plus Paclitaxel, S-1 and Apatinib for Unresectable Advanced G/GEJ Cancer | unknown | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 10, 2023 | clinicaltrials |
| NCT05842187 | In Vitro Organoid Drug Sensitivity-Guided Treatment for Metastatic Pancreatic and Gastric Cancer(ODYSSEY) | unknown | N/A | 20 | Jianzhen Shan, MDOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT05844371 | Efficacy and Safety of Tirelizumab Plus Chemotherapy Versus Chemotherapy Alone in Patients With Lymph Node Positive Gastric Cancer After Surgery | unknown | Phase 2 | 60 | Yixing People's HospitalOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT05831488 | Assessing the Accuracy of Seismofit® as an Estimate of VO2 Peak in Patients With Hepato-pancreato-biliary, Colorectal, and Gastro-oesophageal Cancer(VERVE) | unknown | — | 35 | Royal Marsden NHS Foundation TrustOTHER | 1 | Apr 26, 2023 | clinicaltrials |
| NCT04819971 | Study of Perioperative Chemotherapy Combined With Tislelizumab and Trastuzumab in the Treatment of GC/EGC | unknown | Phase 2 | 67 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Apr 25, 2023 | clinicaltrials |
| NCT04609176 | Study of Camrelizumab (SHR-1210) and Apatinb Based Therapies for Alpha-fetoprotein (AFP)-Producing Gastric Cancer or Gastroesophageal Junction Adenocarcinoma | unknown | Phase 2 | 64 | Peking UniversityOTHER | 1 | Apr 21, 2023 | clinicaltrials |
| NCT05816863 | Clinical Study of Pabolizumab for Neoadjuvant Immunotherapy of Locally Advanced Microsatellite-unstable Gastric Adenocarcinoma | unknown | — | 32 | Peking University Cancer Hospital & InstituteOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT05052931 | Nab-paclitaxel Combined With Oxaliplatin and S-1 for Perioperative Treatment of Advanced Gastric Cancer | unknown | Phase 2 | 10 | Jianjun YangOTHER | 1 | Apr 13, 2023 | clinicaltrials |
| NCT05811546 | Immunohistochemical Evaluation of DNA Methylation and Histone Modification in H. Pylori Associated Gastric Carcinoma | unknown | — | 68 | Assiut UniversityOTHER | 1 | Apr 13, 2023 | clinicaltrials |
| NCT05805956 | IMM2902 in Patients With Advanced Solid Tumors Expressing HER2 | unknown | Phase 1 / Phase 2 | 105 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc.OTHER | 1 | Apr 10, 2023 | clinicaltrials |
| NCT05800080 | An Exploratory Study of Immunotherapy Combined With Anlotinib and Chemotherapy in Perioperative Treatment of LAGC | unknown | N/A | 114 | Xijing HospitalOTHER | 1 | Apr 5, 2023 | clinicaltrials |
| NCT05800236 | Characterisation of the Intratumoral Microbiome in Gastric Adenocarcinoma: to a Personalised Medicine(MICROGAS) | unknown | N/A | 20 | University Hospital, BordeauxOTHER | 1 | Apr 5, 2023 | clinicaltrials |
| NCT04850716 | Relationship Between Standard Treatment Efficacy and The Tumor Microenvironment in Advanced Gastric Cancer | unknown | — | 89 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Mar 28, 2023 | clinicaltrials |
| NCT05785234 | The Effects of Sufentanil vs. Remifentanil in Total Intravenous Anesthesia With Remimazolam on Postoperative Pain | unknown | N/A | 66 | Yonsei UniversityOTHER | 1 | Mar 27, 2023 | clinicaltrials |
| NCT05541146 | Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis | unknown | Phase 2 | 30 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Mar 23, 2023 | clinicaltrials |
| NCT05633342 | Project CADENCE (CAncer Detected Early caN be CurEd)(CADENCE) | unknown | — | 15,000 | MiRXES Pte LtdINDUSTRY | 1 | Mar 20, 2023 | clinicaltrials |
| NCT05775120 | Epidemiology of Helicobacter Pylori Infection in Moscow | unknown | — | 5,121 | Moscow Clinical Scientific CenterOTHER | 1 | Mar 20, 2023 | clinicaltrials |
| NCT05769725 | A Study to Evaluate Serplulimab in Combination With Docetaxel +S-1 VS. Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage IIIc Gastric Cancer | unknown | Phase 2 | 70 | RenJi HospitalOTHER | 1 | Mar 15, 2023 | clinicaltrials |
| NCT05192460 | Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer, Esophageal Cancer and Liver Cancer | unknown | N/A | 30 | jianming xuOTHER | 1 | Mar 7, 2023 | clinicaltrials |
| NCT02197351 | Narrow Band Imaging for Gastric Neoplasia | unknown | N/A | 220 | University of Southern CaliforniaOTHER | 2 | Mar 6, 2023 | clinicaltrials |
| NCT05750290 | CKD-702 Plus Irinotecan in Gastric Cancer | unknown | Phase 2 | 40 | National Cancer Center, KoreaOTHER_GOV | 1 | Mar 1, 2023 | clinicaltrials |
| NCT03399071 | Study Title: Peri-operative Immuno-Chemotherapy in Operable Oesophageal and Gastric Cancer(ICONIC) | unknown | Phase 2 | 44 | Royal Marsden NHS Foundation TrustOTHER | 1 | Feb 21, 2023 | clinicaltrials |
| NCT04618809 | Improving the Approach to and Management of the Older Patient With Metastatic Gastric Cancer | unknown | N/A | 100 | Fox Chase Cancer CenterOTHER | 1 | Feb 15, 2023 | clinicaltrials |
| NCT05728606 | Robot-assisted D2 Distal Gastrectomy Following Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancers | unknown | N/A | 70 | Hebei Medical UniversityOTHER | 1 | Feb 15, 2023 | clinicaltrials |
| NCT05160753 | Laparoscopic Gastric Function Preserving Surgery Combined With Resection of the Anterior Lymphatic Drainage Area | unknown | N/A | 580 | Affiliated Hospital of Nantong UniversityOTHER | 1 | Feb 9, 2023 | clinicaltrials |
| NCT05720533 | Disitamab Vedotin Combined With Sintilimab as First-line Treatment of Elderly Patients With Gastric Cancer | unknown | Phase 2 | 20 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Feb 9, 2023 | clinicaltrials |
| NCT05720598 | Staging LaParoscopy to Assess Lymph NOde InvoLvement in Advanced GAstric Cancer(POLA) | unknown | N/A | 190 | Medical University of LublinOTHER | 1 | Feb 9, 2023 | clinicaltrials |
| NCT04791254 | Anorexia iN Cancer Patients: ANCHOR(ANCHOR) | unknown | — | 450 | The Christie NHS Foundation TrustOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT05583201 | NKG2D/CLDN18.2 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumors | unknown | Early Phase 1 | 18 | jianming xuOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT05513144 | Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric Cancer | unknown | — | 30 | chenwuOTHER | 1 | Feb 6, 2023 | clinicaltrials |
| NCT03995017 | Rucaparib Plus Ramucirumab With or Without Nivolumab in Advanced Gastric and Esophageal Adenocarcinoma(RiME) | unknown | Phase 1 / Phase 2 | 34 | University of Kansas Medical CenterOTHER | 1 | Feb 1, 2023 | clinicaltrials |
| NCT05325528 | Study of Tislelizumab in Combination With SOX for the Treatment of Gastric Cancer With Liver Metastases | unknown | Phase 2 / Phase 3 | 40 | Zhejiang UniversityOTHER | 1 | Feb 1, 2023 | clinicaltrials |
| NCT04222114 | Comparing the Efficacy and Safety of Intra-peritoneal Infusion of Catumaxomab and Treatment of Investigator Choice in Patients With Advanced Gastric Carcinoma With Peritoneal Metastasis | unknown | Phase 3 | 282 | LintonPharm Co.,Ltd.INDUSTRY | 3 | Jan 31, 2023 | clinicaltrials |
| NCT05453825 | A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors | unknown | Phase 2 | 180 | OncXerna Theraputics, Inc.INDUSTRY | 1 | Jan 31, 2023 | clinicaltrials |
| NCT05705635 | A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer | unknown | Phase 2 | 100 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Jan 31, 2023 | clinicaltrials |
| NCT05707338 | Short-term Outcomes of Laparoscopic Versus Open Gastrectomy With Lymph Node Dissection for Early Gastric Cancer :a Randomized Controlled Study | unknown | N/A | 40 | Sohag UniversityOTHER | 0 | Jan 31, 2023 | clinicaltrials |
| NCT05693519 | GastroIntestinal Cancer in Children and Adolescents(GICCA) | unknown | — | 2,500 | Paul G. Kemps, MDOTHER | 1 | Jan 23, 2023 | clinicaltrials |
| NCT05687552 | Role of 18F-FDG PET/CT in Gastric Cancer | unknown | — | 50 | Sohag UniversityOTHER | 0 | Jan 18, 2023 | clinicaltrials |
| NCT05668910 | Gastric Cancer Early Detection by Multi-dimensional Analysis of cfDNA | unknown | — | 360 | GeneCast Biotechnology Co., Ltd.INDUSTRY | 1 | Dec 30, 2022 | clinicaltrials |
| NCT03775525 | Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer(GEN602) | unknown | Phase 1 | 127 | Genzada Pharmaceuticals USA, Inc.INDUSTRY | 1 | Dec 23, 2022 | clinicaltrials |
| NCT04232735 | Evidence Based Information Provision to Improve Decision Making After Oesophagogastric Cancer Diagnosis (SOURCE)(SOURCE) | unknown | N/A | 126 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Dec 16, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Jun 13, 2023source: clinicaltrials